Screening Breast MR Imaging in Women with a History of Lobular Carcinoma in Situ

References

• 1 Morris EA, Liberman L, Ballon DJ, et al.. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 2003;181(3):619–626.
  Medline Google Scholar
• 2 Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med 2000;342(8):564–571.
  Medline Google Scholar
• 3 Dershaw DD. Mammographic screening of the high-risk woman. Am J Surg 2000;180(4):288–289.
  Medline Google Scholar
• 4 Simpson PT, Gale T, Fulford LG, Reis-Filho JS, Lakhani SR. The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ. Breast Cancer Res 2003;5(5):258–262.
  Medline Google Scholar
• 5 Arpino G, Laucirica R, Elledge RM. Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med 2005;143(6):446–457.
  Medline Google Scholar
• 6 Li CI, Malone KE, Saltzman BS, Daling JR. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988–2001. Cancer 2006;106(10):2104–2112.
  Medline Google Scholar
• 7 Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW. Lobular carcinoma in situ of the breast: detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 1978;2(3):225–251.
  Medline Google Scholar
• 8 Bluemke DA, Gatsonis CA, Chen MH, et al.. Magnetic resonance imaging of the breast prior to biopsy. JAMA 2004;292(22):2735–2742.
  Medline Google Scholar
• 9 Kuhl CK, Schrading S, Leutner CC, et al.. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005;23(33):8469–8476.
  Medline Google Scholar
• 10 Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001;220(1):13–30.
  Google Scholar
• 11 Lee CH, Dershaw DD, Kopans D, et al.. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 2010;7(1):18–27.
  Medline Google Scholar
• 12 Saslow D, Boetes C, Burke W, et al.. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57(2):75–89.
  Medline Google Scholar
• 13 Port ER, Park A, Borgen PI, Morris E, Montgomery LL. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol 2007;14(3):1051–1057.
  Medline Google Scholar
• 14 D’Orsi CJ, Bassett LW, Berg WA, et al.. Breast Imaging Reporting and Data System: ACR BI-RADS-Mammography. 4th ed. Reston, Va: American College of Radiology, 2003.
  Google Scholar
• 15 Clopper C, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934;26(4):404–413.
  Google Scholar
• 16 McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 1947;12(2):153–157.
  Medline Google Scholar
• 17 Obuchowski NA. Nonparametric analysis of clustered ROC curve data. Biometrics 1997;53(2):567–578.
  Medline Google Scholar
• 18 Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94(446):496–509.
  Google Scholar
• 19 Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16(3):1141–1154.
  Google Scholar
• 20 Hellquist BN, Duffy SW, Abdsaleh S, et al.. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer 2011;117(4):714–722.
  Medline Google Scholar
• 21 Lehman CD. Role of MRI in screening women at high risk for breast cancer. J Magn Reson Imaging 2006;24(5):964–970.
  Medline Google Scholar
• 22 Kriege M, Brekelmans CT, Boetes C, et al.. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351(5):427–437.
  Medline Google Scholar
• 23 Kuhl CK, Schmutzler RK, Leutner CC, et al.. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000;215(1):267–279.
  Google Scholar
• 24 Warner E, Plewes DB, Shumak RS, et al.. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001;19(15):3524–3531.
  Medline Google Scholar
• 25 Page DL, Kidd TE, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991;22(12):1232–1239.
  Medline Google Scholar
• 26 Warner E, Plewes DB, Hill KA, et al.. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292(11):1317–1325.
  Medline Google Scholar
• 27 Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 2008;148(9):671–679.
  Medline Google Scholar
• 28 Plevritis SK, Kurian AW, Sigal BM, et al.. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA 2006;295(20):2374–2384.
  Medline Google Scholar